## **Core Concept**
The management of infertility in women with Polycystic Ovary Syndrome (PCOS) often involves ovulation induction. PCOS is characterized by ovulatory dysfunction, hyperandrogenism, and polycystic ovaries. The goal of follicle induction is to stimulate the growth and release of eggs.

## **Why the Correct Answer is Right**
Letrozole, an aromatase inhibitor, is considered the drug of choice for follicle induction in women with PCOS. It works by inhibiting the conversion of androgens to estrogens, which leads to an increase in follicle-stimulating hormone (FSH) production. This increase in FSH stimulates follicular growth and ovulation. Letrozole has been shown to have a higher ovulation rate and a lower risk of multiple gestations compared to clomiphene citrate.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Clomiphene citrate, a selective estrogen receptor modulator (SERM), is traditionally used for ovulation induction but has a lower efficacy rate compared to letrozole in women with PCOS and a higher risk of multiple gestations.
* **Option B:** Gonadotropins (e.g., FSH) can be used for ovulation induction but are typically considered second-line due to their higher cost, need for injections, and increased risk of ovarian hyperstimulation syndrome (OHSS).
* **Option D:** Metformin, an insulin-sensitizing agent, can help improve ovulation in women with PCOS who have insulin resistance but is not a direct stimulator of follicular growth.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that letrozole has become a preferred agent over clomiphene citrate for ovulation induction in PCOS due to its efficacy and safety profile.

## **Correct Answer:** . Letrozole.